2nd Quarter - Report
W STRATEGIES, LLC for ABBOTT LABORATORIES
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to corporate tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Development of legislation regulated to regulation of LDT's, including a discussion draft of Diagnostic Accuracy and Improvement Act. Issues related to WHO and diagnostic tests. H.R. 1628: American Health Care Act of 2017. H.R.2430: FDA Reauthorization Act of 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Medicare quality measures related to malnutrition among older Americans. Implementation of PAMA (Protecting Access to Medicare Act of 2014).
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.